Cargando…

Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma

Detalles Bibliográficos
Autor principal: Markers, Disease
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371707/
https://www.ncbi.nlm.nih.gov/pubmed/37502593
http://dx.doi.org/10.1155/2023/9781753
_version_ 1785078208082739200
author Markers, Disease
author_facet Markers, Disease
author_sort Markers, Disease
collection PubMed
description
format Online
Article
Text
id pubmed-10371707
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103717072023-07-27 Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma Markers, Disease Dis Markers Retraction Hindawi 2023-07-19 /pmc/articles/PMC10371707/ /pubmed/37502593 http://dx.doi.org/10.1155/2023/9781753 Text en Copyright © 2023 Disease Markers. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Markers, Disease
Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
title Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
title_full Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
title_fullStr Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
title_full_unstemmed Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
title_short Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
title_sort retracted: the higher expression of cdca2 associated with poor prognosis in glioma
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371707/
https://www.ncbi.nlm.nih.gov/pubmed/37502593
http://dx.doi.org/10.1155/2023/9781753
work_keys_str_mv AT markersdisease retractedthehigherexpressionofcdca2associatedwithpoorprognosisinglioma